Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo
$0.0020 0.00 (0.00%)
As of 07/3/2025

About Acutus Medical Stock (NASDAQ:AFIB)

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
$0.00
$0.05
52-Week Range
$0.00
$0.22
Volume
N/A
Average Volume
33,047 shs
Market Capitalization
$59.56 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

AFIB Acutus Medical, Inc. - Seeking Alpha
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical's stock was trading at $0.0550 on January 1st, 2025. Since then, AFIB stock has decreased by 96.4% and is now trading at $0.0020.

Acutus Medical, Inc. (NASDAQ:AFIB) announced its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.02. The firm had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%.

Acutus Medical subsidiaries include these companies: Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto (RIO).

Company Calendar

Last Earnings
11/11/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AFIB
Employees
340
Year Founded
2011

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%

Debt

Sales & Book Value

Annual Sales
$7.16 million
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-0.07

Miscellaneous

Free Float
28,228,000
Market Cap
$59.56 thousand
Optionable
Optionable
Beta
-0.34

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners